VSIR and breast carcinoma: To evaluate the effect of siRNA-mediated silencing on the genes of the VISTA/VSIG3/PSGL-1 axis, specific siRNAs were transfected into the MDA-MB-231 and T-47D breast cancer cell lines for 24 h and 48 h.